Clinical investigation of human plasma-derived von Willebrand factor products - Scientific guideline

This document summarises the clinical trials required for authorisation of new and modified human plasma derived von Willebrand factor products.

Keywords: Von Willebrand factor, von Willebrand disease

Current effective version

Guideline on the clinical investigation of human plasma derived Von Willebrand factor products (CPMP/BPWG/220/02)

AdoptedReference Number: CPMP/BPWG/220/02Legal effective date: 01/06/2006